Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases Read more about Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn Read more about Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn
Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August Read more about Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence Read more about 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
Amgen to Present at the Goldman Sachs Global Healthcare Conference Read more about Amgen to Present at the Goldman Sachs Global Healthcare Conference
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP Read more about New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance Read more about New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
VIDEO from Medialink and Amgen: New Survey Highlights Growing Concern About Risk of Infection and Emerging Antibiotic Resistance in Cancer Patients Read more about VIDEO from Medialink and Amgen: New Survey Highlights Growing Concern About Risk of Infection and Emerging Antibiotic Resistance in Cancer Patients
Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 Read more about Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452
Amgen Highlights Data to Be Presented at ASCO Read more about Amgen Highlights Data to Be Presented at ASCO
